Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-01-02

Clinical Trial Update: Could miRNAs be Used as Markers for Distinguishing Undescended Testicles From Retractile Testicles

View source ↗

Summary

A completed clinical trial evaluated whether microRNAs can serve as biomarkers to distinguish undescended testes from retractile testicles.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Dr. Mevlüt Keleş | Conditions: MIRAS, Testicular Abnominalies | Status: COMPLETED